Subcutaneous Galcanezumab May Help Prevent Episodic Migraines

Share this content:
Subcutaneous Galcanezumab May Help Prevent Episodic Migraines
Subcutaneous Galcanezumab May Help Prevent Episodic Migraines

MONDAY, Dec. 18, 2017 (HealthDay News) -- Monthly subcutaneous injections of galcanezumab are efficacious in prevention of episodic migraine headaches, according to a study published online Dec. 18 in JAMA Neurology.

Vladimir Skljarevski, M.D., from Eli Lilly and Company in Indianapolis, and colleagues randomly assigned 410 patients with episodic migraine headaches to receive placebo or galcanezumab (5, 50, 120, or 300 mg) over a three-month treatment period.

The enrolled patients experienced four to 14 migraine headache days per month. The researchers found that, compared to placebo, galcanezumab (120 mg) significantly reduced migraine headache days (99.6 percent posterior probability, −4.8 days). Five percent or more of patients reported the following adverse events more frequently than placebo participants: injection-site pain, upper respiratory tract infection, nasopharyngitis, dysmenorrhea, and nausea.

"Monthly subcutaneous injections of galcanezumab, both 120 mg and 300 mg, demonstrated efficacy (repeated-measures analysis) for the preventive treatment of migraine and support further development in larger phase 3 studies," the authors write. "All dosages were safe and well tolerated for the preventive treatment of episodic migraine."

Several authors disclosed financial ties to pharmaceutical companies, including Eli Lilly, which manufacturers galcanezumab and funded the study.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Lap Sleeve Gastrectomy, RYGB Equally Effective in Weight Loss

Lap Sleeve Gastrectomy, RYGB Equally Effective in Weight ...

Studies show no significant difference in BMI loss at five years between these laparoscopic procedures

ASCO: Liquid Biopsy Accurate for Detecting Colorectal Cancer

ASCO: Liquid Biopsy Accurate for Detecting Colorectal Cancer

Novel assay to detect circulating tumor cells has high sensitivity, specificity for precancerous lesions

Speech Outcomes Can Be Predicted After Cochlear Implant

Speech Outcomes Can Be Predicted After Cochlear Implant

Regions of brain that were unaffected by auditory deprivation provide most precise prediction results

is free, fast, and customized just for you!

Already a member?

Sign In Now »